Active	Status	Sponsor type	Region	Phase	Filter
1 Active 10 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
elismetrep (MT-8554) / Mitsubishi Tanabe, Kallyope
NCT06848075: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine	Recruiting	2	400	US	Elismetrep (K-304) Dose Level 1, Elismetrep (K-304) Dose level 2, Elismetrep (K-304) Dose level 3, Elismetrep (K-304) Dose level 4, Placebo	Kallyope Inc.	Acute Migraine	12/25	12/25